Of all the conversations you might expect to hear inside the players’ room at the World Darts Championship, eating times, ...

My name is Todd Tushla, I'm the Vice President of Investor Relations at Neurocrine Biosciences. And on behalf of our entire company, welcome to our 2025 R&D Day, whether you're here in person, on the ...

Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...